These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 31621389

  • 1. Overexpression of Long Noncoding RNA E2F-Mediated Cell Proliferation Enhancing Long Noncoding RNA Is Involved in the Development of Chemoresistance of Cancer Cells to Carboplatin in Ovarian Endometrioid Adenocarcinoma.
    Zhao L, Yang J, Liu X, Fu X, Ding Y, Wang C.
    Cancer Biother Radiopharm; 2019 Nov; 34(9):566-571. PubMed ID: 31621389
    [Abstract] [Full Text] [Related]

  • 2. The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation.
    Wang H, Fang L, Jiang J, Kuang Y, Wang B, Shang X, Han P, Li Y, Liu M, Zhang Z, Li P.
    Cell Death Dis; 2018 Oct 30; 9(11):1103. PubMed ID: 30375398
    [Abstract] [Full Text] [Related]

  • 3. Long Non-Coding RNA (lncRNA) BMP/OP-Responsive Gene (BORG) Promotes Development of Chemoresistance of Colorectal Cancer Cells to Carboplatin.
    Li J, Ma J, Zhang X, Tai X, Liu L, Zhang L.
    Med Sci Monit; 2020 Jan 15; 26():e919103. PubMed ID: 31937750
    [Abstract] [Full Text] [Related]

  • 4. The LncRNA EPEL Promotes Lung Cancer Cell Proliferation Through E2F Target Activation.
    Park SM, Choi EY, Bae DH, Sohn HA, Kim SY, Kim YJ.
    Cell Physiol Biochem; 2018 Jan 15; 45(3):1270-1283. PubMed ID: 29448242
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cells.
    Zarogoulidis P, Petanidis S, Kioseoglou E, Domvri K, Anestakis D, Zarogoulidis K.
    Cell Signal; 2015 Aug 15; 27(8):1576-88. PubMed ID: 25917317
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. HOTAIR is a potential target for the treatment of cisplatin‑resistant ovarian cancer.
    Wang Y, Wang H, Song T, Zou Y, Jiang J, Fang L, Li P.
    Mol Med Rep; 2015 Aug 15; 12(2):2211-6. PubMed ID: 25824616
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-370 suppresses proliferation and promotes endometrioid ovarian cancer chemosensitivity to cDDP by negatively regulating ENG.
    Chen XP, Chen YG, Lan JY, Shen ZJ.
    Cancer Lett; 2014 Oct 28; 353(2):201-10. PubMed ID: 25063739
    [Abstract] [Full Text] [Related]

  • 14. p53 mutations and overexpression affect prognosis of ovarian endometrioid cancer but not clear cell cancer.
    Okuda T, Otsuka J, Sekizawa A, Saito H, Makino R, Kushima M, Farina A, Kuwano Y, Okai T.
    Gynecol Oncol; 2003 Mar 28; 88(3):318-25. PubMed ID: 12648581
    [Abstract] [Full Text] [Related]

  • 15. T-Type Ca2+ Channel Inhibition Sensitizes Ovarian Cancer to Carboplatin.
    Dziegielewska B, Casarez EV, Yang WZ, Gray LS, Dziegielewski J, Slack-Davis JK.
    Mol Cancer Ther; 2016 Mar 28; 15(3):460-70. PubMed ID: 26832797
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.